Concepedia

Silvia González

SG

Statistics

Publications

6

Citations

218

H-Index

6

Active since

2009

Affiliations

GlaxoSmithKline (Spain)(Current)

Wellcome Centre for Anti-Infectives Research

GlaxoSmithKline (United Kingdom)

Instituto de Parasitología y Biomedicina "López - Neyra"

GlaxoSmithKline (France)

Silvia González is an author at GlaxoSmithKline (Spain) specializing in pharmacology, drug discovery, and medicinal chemistry.

ORCID

Publications per year

2009–2023

6

Publications

6

Identification and Characterization of Hundreds of Potent and Selective Inhibitors of Trypanosoma brucei Growth from a Kinase-Targeted Library Screening Campaign

Rosario Díaz-González, Sandra A. Luengo-Arratta, João Seixas et al. · PLoS neglected tropical diseases · 2014 · 56 citations · Full text

, , +12

Identification of GSK3186899/DDD853651 as a Preclinical Development Candidate for the Treatment of Visceral Leishmaniasis

Michael G. Thomas, Manu De Rycker, Myriam Ajakane et al. · Journal of Medicinal Chemistry · 2018 · 49 citations · Full text

, , +15

Establishment of a Structure–Activity Relationship of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinoline-Based Kinase Inhibitor NVP-BEZ235 as a Lead for African Sleeping Sickness

João Seixas, Sandra A. Luengo-Arratta, Rosario Díaz-González et al. · Journal of Medicinal Chemistry · 2014 · 35 citations · Full text

, , +16

DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc <sub>1</sub>

Stéphanie Braillard, Martine Keenan, Jacob Heppell et al. · Science Translational Medicine · 2023 · 28 citations · Full text

, , +13

2-Arylbenzoxazoles as CETP inhibitors: Substitution and modification of the α-alkoxyamide moiety

Julianne A. Hunt, Silvia González, Florida Kallashi et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 26 citations · Full text

, , +6

1–5 of 6